doi: 10.1248/bpb1978.3.709.
Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA
- PMID: 7277186
- DOI: 10.1248/bpb1978.3.709
Item in Clipboard
Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA
J Pharmacobiodyn.
1980 Dec.
Abstract
KW-5338 (domperidone), a new dopamine antagonist, is considered to be an agent to cross the blood-brain barrier with difficulty. The antagonistic activities of KW-5338 against L-DOPA were investigated, KW-5338 showed a strong anti-emetic action against L-DOPA induced emesis in beagle dogs (ED50=0.056 mg/kg (p.o.)) and restored the L-DOPA induced depression of intestinal motility to some extent, while it did not antagonize anti-tremorine activities of L-DOPA and trihexyphenidyl in mice. These results suggest that KW-5338 prevents side effects of L-DOPA such as nausea, vomiting and constipation, without reduction in therapeutic effects of L-DOPA in Parkinson's disease.
Similar articles
-
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.Drugs. 1982 Nov;24(5):360-400. doi: 10.2165/00003495-198224050-00002. Drugs. 1982. PMID: 6756878 Review.
-
Effects of KW-5338 (domperidone) on gastric motility.J Pharmacobiodyn. 1980 Dec;3(12):715-9. doi: 10.1248/bpb1978.3.715. J Pharmacobiodyn. 1980. PMID: 7277187
-
Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs.Jpn J Pharmacol. 1996 Jun;71(2):129-37. doi: 10.1254/jjp.71.129. Jpn J Pharmacol. 1996. PMID: 8835639
-
Inhibition of reverse peristalsis of the intestine by domperidone.Scand J Gastroenterol Suppl. 1981;67:199-200. Scand J Gastroenterol Suppl. 1981. PMID: 6941409
-
Domperidone: a peripherally acting dopamine2-receptor antagonist.Ann Pharmacother. 1999 Apr;33(4):429-40. doi: 10.1345/aph.18003. Ann Pharmacother. 1999. PMID: 10332535 Review.
Cited by
-
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.Drugs. 1982 Nov;24(5):360-400. doi: 10.2165/00003495-198224050-00002. Drugs. 1982. PMID: 6756878 Review.
-
Domperidone prolongs oral to duodenal transit time in video capsule endoscopy.Eur J Clin Pharmacol. 2018 Apr;74(4):521-524. doi: 10.1007/s00228-017-2399-8. Epub 2017 Dec 8. Eur J Clin Pharmacol. 2018. PMID: 29222714
-
Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the Evidence.J Exp Pharmacol. 2021 Mar 29;13:397-408. doi: 10.2147/JEP.S267032. eCollection 2021. J Exp Pharmacol. 2021. PMID: 33824605 Free PMC article. Review.